CI U.S. Stock Selection Private Pool

Series I CAD

Not available to retail investors / for approved investors only
 

Fund overview

The pool’s investment objective is to provide long-term capital growth by investing primarily in large-cap U.S. equity and equity-related securities. Any change to the fundamental investment objective must be approved by a majority of votes cast at a meeting of securityholders held for that reason.

Fund details

description of elementelement value
Inception date August 2025
CAD Total net assets ($CAD)
As at 2025-12-31
$809.5 thousand
NAVPS
As at 2026-01-21
$10.7233
MER (%)
As at 2025-09-30
0.00
Management fee (%) Negotiable
Asset class U.S. Equity
Currency CAD
Minimum investment Negotiable
Distribution frequency Annually
Last distribution $0.0305

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

I 5034
A 2034
F 4034

Performance2 As at 2025-12-31

*Fund performance is not available for funds with a history of less than one year.

Distribution history3

Payable date Total
2025-12-29 0.0305

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Jeremy Rosa
Peter Hofstra

CI U.S. Stock Selection Private Pool

Series I CAD

Not available to retail investors / for approved investors only
 
Portfolio allocations4 As at 2025-12-31
Asset allocation (%)
  • US Equity 88.01
  • International Equity 7.41
  • Canadian Equity 2.63
  • Cash and Equivalents 1.92
  • Other 0.03
Sector allocation (%)
  • Technology 51.72
  • Healthcare 27.86
  • Financial Services 8.61
  • Consumer Services 8.37
  • Cash and Cash Equivalent 1.92
  • Energy 1.49
  • Other 0.03
Geographic allocation(%)
  • United States 67.18
  • Canada 25.38
  • United Kingdom 2.57
  • Taiwan 2.01
  • Cayman Islands 1.56
  • Netherlands 1.27
  • Other 0.03
Top holdings5
Sector (%)
1. CASH Cash and Cash Equivalent 20.09%
2. NVIDIA Corp Computer Electronics 9.36%
3. Microsoft Corp Information Technology 8.45%
4. Alphabet Inc Cl C Information Technology 7.08%
5. Amazon.com Inc Retail 5.71%
6. Eli Lilly and Co Drugs 4.37%
7. Meta Platforms Inc Cl A Information Technology 4.25%
8. Broadcom Inc Computer Electronics 4.23%
9. Thermo Fisher Scientific Inc Healthcare Equipment 3.83%
10. AbbVie Inc Drugs 3.56%
11. Intuitive Surgical Inc Healthcare Equipment 3.36%
12. Mastercard Inc Cl A Diversified Financial Services 3.29%
13. Apple Inc Computer Electronics 3.18%
14. DexCom Inc Healthcare Equipment 2.90%
15. Vertex Pharmaceuticals Inc Drugs 2.61%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.